COGT — Cogent Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual balance sheet for Cogent Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	37.4	242	220	259	266
Net Total Accounts Receivable
Net Total Receivables	2	0	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	40.6	245	223	265	271
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.15	4.75	4.48	31.1	30.3
Long Term Investments
Other Long Term Assets
Total Assets	49.4	251	232	301	313
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	13.2	13.1	17.1	26.8	38.2
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.7	16.2	17.9	45.1	55.6
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	31.8	235	214	256	258
Total Liabilities & Shareholders' Equity	49.4	251	232	301	313
Total Common Shares Outstanding
Total Preferred Shares Outstanding